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IMPORTANT NOTE REGARDING RESEARCH SUMMARY 
AND REFERENCES 
It is imperative to note that the essence of modern research is summarised in the word ‘col-
laboration’. It should thus be taken to heart that the work described here, while described as 
being ‘my’ research achievement, has been performed in collaboration with numerous other 
worthy contributors, be they academics or students. In particular, my former colleagues at 
WITS, particularly Profs de Koning, Coville and Michael, deserve much of the acclaim; it is due 
to their support during my time at WITS that I was able to oversee any research at all, and 
they have my deepest thanks for their team spirit. Furthermore, while compiling this summary 
it quickly became obvious that I would not be able to do justice to the other phenomenal re-
searchers active in the scientific areas that we have been involved in. Due to space limitations 
I have therefore only listed publications to which we have contributed, and I humbly apologise 
for not being able to cite all the seminal work in the literature. The reader should thus be 
aware that our work forms a ‘brick in the wall of science’ and that the references in our actual 
papers give due credit to the other researchers involved.
INTRODUCTION
On joining WITS as a lecturer in June 2001, my fascination with a new synthetic ‘methodology-
on-the-block’, namely metal-catalysed metathesis, was 
already in place. The synthetic methodology research 
work from our group based on this theme and per-
formed in the formative years of my research career 
will be described in the first part of this summary. 
This will be followed by our adventures into the synthesis 
of functional molecules, in other words molecules 
created for a particular objective, be it application in 
nanomaterials, medicinal chemistry or biological systems.
APPLICATIONS OF METATHESIS, 
ISOMERISATIONS AND OTHER 
REACTIONS TO THE SYNTHESIS OF 
BENZO-FUSED COMPOUNDS
To an organic chemist the term ‘metathesis’ brings to mind the interaction of two alkenes, two alkynes or 
an alkene with an alkyne to generate new unsaturated 
substrates, as demonstrated by the two examples of 
ene-ene-cross metathesis (CM) and ring-closing meta-
thesis (RCM) shown in Scheme 1. Of particular interest 
has been RCM, which results in carbo- or heterocycles 
with an internal unsaturated bond (see Scheme 1). 
Over the past two decades the advances in the field of 
metathesis have been facilitated by the development 
of modern metal-carbene catalysts, exemplified by the 
Grubbs first and second generation ruthenium catalysts 
(1 and 2, respectively), the Schrock molybdenum 
catalyst 3 and the ruthenium Hoveyda-Grubbs catalyst 
4, as depicted in Figure 1 (for an exhaustive list of 
reviews on the topic of metathesis see reference1). 
As an aside, the metathesis pioneers Grubbs, Schrock 
and Chauvin received the Nobel Prize for chemistry 
(2005) due to their fundamental contributions to 
meta thesis chemistry. I distinctly remember my initial 
interest of applying this methodology to a target group 
of so-called benzo-fused heterocycles, molecules 
in which an interest had been born during my PhD 
days.
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 Scheme 1
Figure 1: Examples of modern 
catalysts used in metathesis
The reason for our fascination with the benzo-
fused classes of compounds is that they are frequently 
found as structural motifs in natural products and as 
a consequence in pharmaceutically relevant synthetic 
compounds. It is because of these characteristics that 
benzannulated compounds are often referred to as 
‘privileged scaffolds’. Figure 2 shows a very limited 
number of natural products and bioactive compounds 
(5–13), all with aromatic rings fused to heterocyclic rings 
of varying size and containing different heteroatoms. 
In 2003, our first research work was published, 
which described a metathetic synthetic approach to the 
synthesis of a number of substituted chromenes 16, a 
naphthalene, a naphthol and an indenol 18 (see Scheme 
2).2 This paper set the scene for a solid number of other 
publications from our group as it became clear that the 
methodology had broad applicability to the synthesis 
of benzo-fused compounds. Of interest was that the 
synthesis of the chromenes required a vinylation, 
followed by a metathesis reaction involving a vinyl ether 
functional group. This work represented one of the 
early examples of the successful metathesis reaction on 
an electron-rich O-vinyl alkene (for extension of this 
work to both 2H- and 4H-chromenes see reference3). 
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Figure 2: Examples of benzo-fused, bioactive and naturally occurring compounds
This paper was followed in the same year by work 
describing the metathesis of more examples involving 
vinyloxy groups – this time being introduced by a 
ruthenium-catalysed isomerisation process of an allyl 
functional group using ruthenium hydride complex 22 
(see Scheme 3).4 These initial results utilised the bis-
isomerisation of 1,2-bis-allyloxybenzenes 19, followed 
by RCM of substrate 20 to afford substituted benzo[1,4]
dioxins 21 in excellent yields over the two steps. The 
isomerisation-RCM protocol could even be performed 
in a one-pot manner in which the metathesis catalyst 
was added after the isomerisation process was deemed 
complete. In addition, the bis-isomerisation of allyl-2-
(allyloxy)benzene 26, followed by introduction of the 
Grubbs second generation catalyst 2, also afforded the 
benzofuran skeleton 28 (via the bis-isomerised compound 
27). Of interest is that both these observations led 
to full papers describing the synthesis of a range of 
substituted benzo[1,4]dioxins5 and benzofurans,6 high-
lighting the applicability of this approach to these ver-
satile benzannulated heterocycles. Subsequently, it was 
even proven that the isomerisation-RCM approach was 
tolerant of S,S-, S,O- and N,O-bis-allylbenzenes, thereby 
affording the benzodithiin 23, 1,4-benzoxathiin 24 and 
4H-1,4-benzoxazine 25 cores, respectively.5
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Scheme 2: Conditions 
and yields: (a) Cu(OAc)2, 
Sn(vinyl)4, MeCN, O2 
(98–99%); (b) 2 (5 mol %), 
toluene (80–98%); 
(c) 2 (5 mol %), 
CH2Cl2 (67%).
Scheme 3: Conditions 
and yields: (a) 22 (1 mol 
%), toluene-d8 or toluene, 
65–100 °C; (b) 2 (5 mol 
%), toluene-d8 or toluene, 
65–80 °C (~70% over 
two steps); (c) 22 (5 mol 
%), toluene or CH2Cl2 
(54%-quantitative); 
(d) 2 (5 mol %), toluene 
(20%-quantitative).
Since the application of an RCM or isomerisation-
RCM approach for the synthesis of benzo-fused com-
pounds with small ring sizes (5 and 6) had been very 
successful, the approach was applied to larger ben-
zannulated heterocycles. Scheme 4 demonstrates 
how the appropriate application of the isomerisation 
and RCM methodologies readily afforded 6-, 7- and 
8-membered ring systems (i.e. compounds 31, 33 and 
29, respectively), irrespective of whether the hete-
roatom in the ring was oxygen or nitrogen.7 Later this 
concept was extended to other aromatic systems8 that 
included the pyridine ring,9 as well as to extensions of 
other heterocycles such as the 2-benzazocine ring.10 Of 
interest is that the latter paper represents one of the 
first examples in which compounds from our laboratory 
were tested for their anti-cancer cytotoxicity, paving the 
way for more bioactivity-inspired synthetic endeavours 
yet to follow.
When working in a new field, there are often surprises 
awaiting the research student in the laboratory, surprises 
that can of course be of synthetic value (in the sciences 
this type of unexpected discovery is often referred to 
as being due to ‘serendipity and the prepared mind’). 
The first unusual reaction occurred during the proposed 
synthesis of dimeric benzo-fused systems using another 
variant of the metathetic arsenal, viz. ene-yne metathesis. 
In contrast to our expectations, instead of the expected 
product 35, compound 36 was isolated (see Scheme 
5).11 This turned out to represent the first reported 
example of a metallotropic [1,3]-shift in 1,3-diynes, me-
diated specifically by a ruthenium carbene. 
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Scheme 4: Conditions and yields: (a) 2 (5 mol %), toluene, 60 °C, 1 h, (52%-quantitative); (b) 22 (5 mol %), toluene, 
80 °C; (c) 2 (5 mol %), toluene, 60–110 °C, 1 h, (52%-quantitative over two steps); (d) 2 (5 mol %), toluene, 60–80 °C, 
2–4 h, (64%-quantitative).
Scheme 5: Conditions and 
yields: (a) 2 (6 mol % x 2), 
toluene, 80 °C, ethylene 
atmosphere (1 atm.), 35, 
0%, 36, 54%. Single crystal 
X-ray structure shown for 36.
A second example involving unexpected results re-
turns to the synthesis of small benzo-fused molecules. 
During attempts to synthesise substituted indenols, it 
became apparent that by simply moderating the reaction 
conditions, the product distribution could be shifted 
to afford indenols 38, indenones 39 or, even in some 
cases, indanones 40 (see Scheme 6).12,13 These results 
were due to the conversion of the Grubbs carbene 
into a ruthenium-hydrido species under the harsher 
high temperature conditions employed, facilitating the 
catalysis of dehydrogenative oxidations and redox 
isomerisations required for the formation of compounds 
of types 39 and 40.
Last in this section on synthetic methodology 
applied in our laboratories, the synthesis of substituted 
tetrahydroisoquinolines (THIQs) by a different route 
will be described. THIQs are also considered privileged 
structures, with many natural products containing this 
motif. See for instance the naphthylisoquinoline alkaloids, 
korupensamine B 41 and michellamine B 42 in Scheme 
7 (analogues of these very compounds being the subject 
of my PhD thesis.14-17 In addition, research performed 
during my postdoctoral fellowship in Montreal, Quebec, 
Canada,18 and during various collaborations on THIQs 
and imbedded THIQs is also part of the reason for 
the interest in the THIQ framework).19,20 While the 
application of an isomerisation-RCM approach to afford 
substituted unsaturated THIQs was unfortunately un-
reliable,21 the application of a reductive mercuration-
hydroamination (i.e. 43 J 44) or an n-butyllithium-
mediated hydroamination approach (i.e. 45 J 46) was 
far more successful.22,23 
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Scheme 6 
Scheme 7: Conditions and 
yields: (a) Hg(OAc)2, THF-
H2O (1/1), rt, 18 h; then 
aq. NaOH, NaBH4, 
0 °C to rt, 18 h (63–90%); 
(b) n-BuLi (2 x 16 mol %), 
rt, 6 h, then 60 °C, 18 h 
(62–87%).
In conclusion to this section, it is evident that our 
approaches to the synthesis of small benzo-fused systems 
have been successful, in particular the application of 
the isomerisation-RCM methodologies. For additional 
examples of our work in this area, including collaborative 
work, see the following references:21,24-26 Furthermore, 
from ongoing work presented in the literature it is 
also clear that these types of reaction will continue to 
enhance the chemist’s ability to synthesise even more 
interesting benzannulated heterocyclic systems. The 
potential of this reaction was highlighted when we (Prof. 
Charles de Koning and I) were honoured in receiving 
an invitation to prepare a comprehensive review arti cle 
entitled ‘Metathesis in the synthesis of aromatic com-
pounds’ for the prestigious journal Chemical Reviews.1 
It is thus envisaged that although much of the present 
research in our laboratories is orientated toward medi-
cinal chemistry (i.e. the synthesis of compounds with 
postulated bioactivity) and chemical biology (i.e. the 
synthesis of molecules as probes in biological systems), 
the application of the metathesis methodology as a 
synthetic strategy will always remain prominent in our 
research.
APPLIED ORGANIC SYNTHETIC 
CHEMISTRY: MOLECULES WITH A 
MISSION 
As mentioned in the conclusion of the last section, while a considerable portion of our research 
time during the last 10 years has been invested in the 
development of novel approaches to the synthesis of 
interesting compound structures, in recent years the 
desire to make molecules that actually ‘do stuff’ has 
become even stronger. In this section of the research 
summary, applications of the molecules made in our 
laboratory will be described. This will include brief de-
scriptions of the synthesis of functionalised carbon 
materials and macrostructures such as lipoplexes, the 
synthesis of compounds with anti-cancer activity based 
on designs from nature and, finally, the design and 
synthesis of compounds to specifically interact with the 
active sites of biological receptors and enzymes.
FUNCTIONALISED ORGANIC 
CARBONACEOUS MATERIALS
The discovery and production of carbonaceous materials such as fullerenes, nanotubes and carbon 
spheres has made a major contribution to advances in the 
field of nanotechnology, i.e. the control of structure on a 
very small size scale, leading to materials with varied and 
valuable properties. Our contribution to this particular 
area of research has been aimed at the functionalisation 
of these carbon-based materials using organic chemistry 
to obtain compounds that may find application in 
materials chemistry, in particular for devices such as 
solar cells and sensors. The work, done in conjunction 
with Prof. N Coville (WITS, CATOMAT group), has 
recently resulted in a number of publications, the first 
involving the metathetic preparation of a polymer con-
taining covalently bound fullerene 51 (see Scheme 8)27 
and the second utilising metals supported on carbon 
spheres as catalysts for organic transformations.28 In the 
last two years, Prof. I Hümmulgen (Federal University 
of Paraná, Curitiba, Brazil) has applied some of the 
synthesised materials in nanoscale devices to obtain 
hydrostatic pressure sensors,29 vapour sensors30 for 
etha nol, methanol and toluene, and finally components 
for simple write-once-read-many-times (WORM) me-
mory devices.31
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SYNTHESIS OF COMPONENTS FOR 
LIPOPLEXES UTILISED IN GENE 
TRANSFER AGENTS
Over the last few years we have also been involved in a fruitful collaboration with Prof. P Arbuthnot 
(Anti-viral Gene Therapy Research Unit, WITS), involving 
the synthesis of novel cholesterol-based components of 
nucleic acid-transporting lipoplexes for the potential 
treatment of hepatitis B. Lipoplexes are nano-sized 
macro structures held together by intermolecular forces 
and have the potential to be important vehicles for drug 
delivery due to a number of advantages. Recently, the 
first publications on this work have described the design 
of novel piperazine- and macrocyclic amine-cholesterol 
derivatives (see for instance piperazine derivative 53 
and cyclen-bis-cholesterol derivative 54 in Scheme 9) 
as key components for lipoplex formulation,32,33 as well 
as their application in a novel gene therapy approach for 
the treatment of hepatitis B, an important disease in the 
South African context.34 
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Scheme 8: Conditions and 
yields: (a) Toluene, rt, 45 
min., (52%); (b) 2 (catalytic), 
xylene, rt, 1 h (83–93 
mass %).
Scheme 9
THE SYNTHESIS OF NATURAL-
PRODUCT-INSPIRED COMPOUNDS 
AS ANTI-CANCER AGENTS 
The animal and plant kingdoms abound with examples of compounds that have wonderful arrays of 
biological activities. It would thus be foolish not to 
utilise these compounds as inspiration for the design of 
‘easier-to-synthesise’ analogues with focused activities 
and fewer off-target interactions (i.e. with fewer side 
effects). With this in mind, we have been involved in a 
number of collaborations – between synthetic chemists, 
molecular modellers, biochemists and structural biolo-
gists – with the specific aim of finding molecules with 
anti-cancer properties. For instance, an international 
collaboration with Prof. A Kornienko (New Mexico 
Institute of Technology and Mining) has involved the 
design and synthesis of analogues, 56, of the cytotoxic 
natural product podophyllotoxin 55. These analogues 
were synthesised in one step by a multi-component 
reaction (see Scheme 10), and this research has re-
cently culminated in a publication.35 The remarkable 
aspect of this work is that many of the compounds 
thus synthesised were at least as potent as the natural 
product; indeed, some analogues were even more ac-
tive. In collaboration with the same American group, 
open-chain analogues of a potent, naturally occurring 
carboisostyril named pancratistatin 57 have also been 
reported.36 Furthermore, work based on the natural 
products lycorine 58,37 purpurogallin 59, colchicine 
60, allocolchicine 61 and others is ongoing, with 
exciting results indicating that the medicinal chemistry 
strategies based on these compounds could result in ‘hit 
compounds’ worth further pharmaceutical investigation. 
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Scheme 10
THE DESIGN AND SYNTHESIS OF 
SMALL MOLECULES DESIGNED TO 
INTERACT WITH BIOMOLECULAR 
ENTITIES 
The indistinct intersection between the areas of chemistry and biology had always been of interest 
to me,38-40 and in 2009 I had the privilege to work with 
a world leader in the area of ‘chemical biology’ – Prof. 
H Waldmann – during a sabbatical stay at the Max 
Planck Institute of Molecular Physiology in Dortmund 
(Germany) as a von Humboldt (Georg-Forster) Re-
search Fellow. During this year I was able to immerse 
myself in a fascinating set of laboratories where the 
worlds of synthetic organic chemistry, biochemistry, 
com putational chemistry and biology were collaborating 
in a symbiosis dedicated to understanding problems in 
the domain of chemical biology. In one of the ongoing 
projects, I was fortunately able to synthesise a set of 
compounds (see for instance compounds 63 and 64 in 
Figure 3) required to support the premise presented in 
a (mostly) computational paper41 describing methodology 
to tra verse ‘chemical space’, thereby highlighting the 
value of organic synthesis in confirming hypotheses. (If I 
had to describe the essence of being an organic chemist 
it would probably be ‘We make – therefore we are’.) 
The scope of the compounds synthesised for this project 
was recently extended to present additional evidence 
for the suitability of the THIQ scaffold being a motif for 
the design of estrogen receptor (ER) modulators.42 The 
ERs belong to the superfamily of nuclear receptors, and 
of interest is that there are two subtypes of ER (ERa 
and ERß), each with unique tissue distribution patterns 
and transcriptional properties. A significant challenge 
in medicinal chemistry has been the identification of 
selective ERβ modulators for the development of po-
ten tial novel tissue and cell-selective drug candidates 
that could be applied in the treatment of cancer and 
inflammatory diseases. Of note is that this project is still 
the topic of collaborative research with the Technical 
University of Eindhoven (Prof. L Brunsveld), with the 
Chemical Genomics Center of the Max Planck Society, 
Dortmund (Dr. C Ottmann), and with a colleague at 
Stellenbosch University (Dr SC Pelly for computational 
modelling investigations).
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Figure 3: (a) General structural fold of the ERβ LBD bound to fragment 63 in complex with an SRC-1 box 2 peptide (red); 
(b) The crystal structure of compound 64 with the ERβ LBD (grey) and overlaid with ERβ LBD - estradiol 62 (magenta; PBD 
3DT3). Only key residues are shown for simplicity.
During my time at the Max Planck Institute, Dort-
mund, I was also very fortunate to engage with an up-
and-coming research leader, Prof. Dr D Rauh (Technical 
University of Dortmund), who is passionately involved 
in research focused on kinases and phosphatases – 
important proteins responsible for the transfer of 
phosphate groups in biostructures and ultimately dictating 
crucial cellular processes such as cell differentiation and 
apoptosis. An enriching time in his laboratories involved 
learning about the importance of kinase deregulations 
and the resultant impact on cells and cancer processes,43 
as well as the importance of having descriptive assay 
systems to evaluate small molecule interactions with 
actual target proteins.44 Other work involved the study 
of actual examples of proteins implicated in human 
oncology (there are more than 500 kinases in the human 
‘kinome’). For instance, a small library of thiazole-based 
compounds was synthesised, based on a design proposed 
to allow interactions with the p38 mitogen-activated 
protein (MAP) kinase active site. The molecules were 
found to display good activity in an enzyme-based 
screen, and the binding mode of these molecules to 
p38a was examined by protein X-ray crystallography, a 
very valuable technique for medicinal chemistry.45 See 
for instance the X-ray crystal structure of compound 
65 in the active site of p38 MAP kinase (Figure 4). 
Further collaborations, involving other topical kinases, 
are currently underway with the Rauh research group, 
and we are optimistic that the results of these studies 
will make important contributions to the field.
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Figure 4: General structure of p38 MAP kinase in (a) surface charge representation and (b) ribbon structure, both with compound 
65 in the active site; (c) Crystal structure of 65 in active site of p38 MAP kinase with only key residues shown for simplicity.
CONCLUSIONS AND A LOOK 
INTO THE FUTURE
It should be evident from this research ‘summary’ that during the course of my career, the beauty of 
molecular interactions between small molecules and 
much larger biological systems has become an ever-
increasing fascination for me. It is in this place between 
the worlds of biology and chemistry that the almost 
overwhelming complexity of multiple yet breathtakingly 
simple intermolecular interactions responsible for 
vast cascades of bioresponses continues to pose fresh 
challenges to scientists attempting to unravel the secrets 
of biological life. As a result, this area of research has 
brought together many weird and wonderful scientific 
bedfellows, including researchers from biological, physi-
cal, computational, medicinal, pharmaceutical and, of 
course, chemical backgrounds; over the last few years I 
have therefore been privileged to have interacted with 
many incredible researchers, and for this I am thankful. 
Many of these researchers are working on the cutting 
edge of their disciplines, and their work has the potential 
to benefit humanity and the wonderful world we live 
in. It is against this picture of complexity that I feel 
organic chemistry still has the potential to play one of 
the most important roles in the understanding of how 
these biological systems function. Amidst the intricacy 
of the tertiary and quaternary structures of protein 
‘behemoths’, the ability to add one carbon to another is 
still a wonderful skill to possess. The power to synthesise 
small molecules of defined structure in a flask, molecules 
containing functional groups so arranged as to be able 
to interact specifically with proteins hundreds of times 
their size, is still of incalculable value to many research 
projects. I am thus tremendously looking forward to the 
challenges before our research group – be it the summons 
to solve a particular tricky synthetic transformation 
in the laboratory or the challenge to come up with a 
small molecule with the ability to modulate a complex 
biomolecule. It is thus with little doubt that I feel our 
research will continue to benefit from the application 
of hardcore organic synthetic chemistry to find answers 
to the questions of our day and age – be it the enigmas 
concerning the issues of energy or materials or the 
conundrums in medicine concerning HIV/Aids, hepatitis, 
tuberculosis or cancer.
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